We can't find the internet
Attempting to reconnect
54121.1 IP-LS
54121.1 IP-LS
Zusammenfassung
alphaRep-HR2 entry inhibitors and a non-antigenic test for the treatment and diagnosis of COVID-19
Weitere Texte
Abstract
The SARS-CoV2 pandemic is a major health, economic and societal issue worldwide. Despite the advent of vaccines, novel therapeutic and diagnostic options are needed. Here, we wish to use S artificial nanoligands to develop novel potent entry inhibitors and a non-antigenic test for massive screening.
Beteiligte
Origène Nyanguile
Kontaktperson
origene.nyanguile@hevs.ch
HES-SO Valais-Wallis Origène Nyanguile Route du Rawyl 64 1950 Sion VS CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2021-05-31
- Enddatum
- 2022-12-31
- Bewilligte Gesamtkosten
- CHF 352488.60
- Sektion
- 60 Life Sciences
- NABS Politikbereich
- Industrielle Produktivität und Technologie
Forschungsdisziplinen
- T410 Pharmaceuticals and related technologies 100.0%